Enrichment analysis showed that the DEGs were significantly enriched in processes related to tumor immunity in addition to the oncogenic pathway, possibly suggesting that ZNF503-AS2 participates in glioma TME remodeling. This evidence concerns the gene ZNF503 and central nervous system cancer.